Physician
Quinn, Adam
Quinn, Adam was paid $711K by Medicaid between Jan 2018 and Oct 2024, across 57 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 44% of everything it billed.
33Billing provider infoQUINN, ADAM
PEORIA, IL 61614
PEORIA, IL 61614
33aNPI1356567044assigned 04/18/2007
33bProvider typeDermatopathology (Pathology) Physician
28Total paid$711K
24GClaims56,973
24DCodes billed57
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Dermatopathology (Pathology) Physician providers in Illinois
Rank by total paid#1 of 10
Median peer was paid$95K
This provider vs. median7.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,967 | $50K | |
| 2019 | 13,192 | $69K | |
| 2020 | 9,190 | $71K | |
| 2021 | 12,923 | $389K | |
| 2022 | 11,806 | $102K | |
| 2023 | 1,634 | $18K | |
| 2024incomplete | 261 | $12K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 44% | 3,797 | 1,763 | $312K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 7.2% | 1,506 | 1,454 | $51K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6.3% | 1,268 | 1,058 | $45K |
| 80053 | Comprehensive metabolic panel | 4.6% | 5,643 | 4,450 | $32K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3.4% | 1,078 | 1,028 | $24K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.3% | 1,043 | 999 | $24K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.7% | 5,491 | 4,006 | $19K |
| 87040 | 1.8% | 1,063 | 821 | $13K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.7% | 507 | 451 | $12K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.7% | 2,277 | 2,070 | $12K |
| 83735 | 1.6% | 3,330 | 1,854 | $12K | |
| 83690 | 1.6% | 3,329 | 2,886 | $11K |
45 more codes
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.5% | 432 | $11K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.4% | 446 | $10K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.4% | 150 | $10K |
| 83605 | 1.4% | 1,778 | $10K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.4% | 184 | $10K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.1% | 1,796 | $8K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.1% | 351 | $8K |
| 84484 | 1.1% | 1,792 | $8K | |
| 85379 | <1% | 1,525 | $6K | |
| 82948 | <1% | 2,448 | $6K | |
| 87430 | <1% | 686 | $5K | |
| 81003 | <1% | 3,395 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 525 | $4K |
| 83880 | <1% | 406 | $4K | |
| 80306 | <1% | 651 | $4K | |
| 87186 | <1% | 619 | $4K | |
| 81001 | <1% | 1,973 | $3K | |
| 87510 | <1% | 231 | $3K | |
| 87480 | <1% | 231 | $3K | |
| 84702 | <1% | 504 | $2K | |
| 86140 | <1% | 938 | $2K | |
| 81025 | <1% | 850 | $2K | |
| 87507 | <1% | 12 | $2K | |
| 85610 | <1% | 875 | $2K | |
| 87660 | <1% | 247 | $2K | |
| 82962 | <1% | 1,058 | $2K | |
| 85027 | <1% | 508 | $2K | |
| 84439 | <1% | 352 | $2K | |
| 84703 | <1% | 354 | $1K | |
| 80061 | Lipid panel | <1% | 304 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 186 | $573.36 |
| 85651 | <1% | 247 | $570.40 | |
| 88307 | <1% | 12 | $549.72 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 86 | $379.66 |
| 86038 | <1% | 43 | $339.70 | |
| 88342 | <1% | 13 | $293.22 | |
| 84100 | <1% | 106 | $251.94 | |
| 87807 | <1% | 45 | $226.35 | |
| 86800 | <1% | 37 | $212.40 | |
| 82077 | <1% | 14 | $145.04 | |
| 81015 | <1% | 110 | $138.86 | |
| 85730 | <1% | 32 | $91.28 | |
| 82565 | <1% | 38 | $86.21 | |
| 87205 | <1% | 33 | $61.25 | |
| 80320 | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.